Skip to main content

Advertisement

SpringerLink
Log in

Study of electronic biofeedback combined with nursing intervention in the treatment of vascular cognitive impairment-no dementia

  • Original article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Objective

To investigate the effects of electronic biofeedback combined with nursing intervention and conventional drug treatment on cognitive function in patients with vascular cognitive impairment-no dementia (VCIND).

Methods

A total of 102 patients with VCIND treated in the Department of Neurology from January 2021 to May 2022 were enrolled and divided into the routine treatment group and biofeedback group according to different treatment methods. The routine treatment group was given conventional drug therapy and nursing intervention; for the biofeedback group, electronic biofeedback therapy was added, based on the routine treatment group. The Montreal Cognitive Assessment, (MoCA), Alzheimer's Disease Assessment Scale-Cognitive Subscale, (ADAS-cog), and Hamilton Depression Scale (HAMD) were checked before treatment, 2 weeks after treatment, and 3 months after treatment.

Results

At 3 months of treatment, the scores of the MoCA and ADAS-cog scales in the biofeedback group were better than those in the routine treatment group, while no difference was detected in the HAMD scores before and after treatment and between the two groups.

Conclusion

Electronic biofeedback therapy for VCIND can significantly improve the MoCA score, reduce the ADAS-cog score and improve the cognitive level of patients and can be used as a complementary treatment for VCIND.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Availability of data and materials

All data generated or analysed during this study are included in this article. Further enquiries can be directed to the corresponding author.

References

  1. Iadecola C, Duering M, Hachinski V et al (2019) Vascular cognitive impairment and dementia: JACC scientific expert panel. J Am Coll Cardiol 73(25):3326–3344

    Article  PubMed  PubMed Central  Google Scholar 

  2. Rundek T, Tolea M, Ariko T et al (2022) Vascular cognitive impairment (VCI). Neurotherapeutics 19(1):68–88

    Article  PubMed  Google Scholar 

  3. Panza F, Lozupone M, Solfrizzi V et al (2018) Different cognitive frailty models and health- and cognitive-related outcomes in older age: from epidemiology to prevention. J Alzheimers Dis 62(3):993–1012

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sun MK (2018) Potential therapeutics for vascular cognitive impairment and dementia. Curr Neuropharmacol 16(7):1036–1044

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Stephan BC, Matthews FE, Khaw KT et al (2009) Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). Alzheimers Res Ther 1(1):4

    Article  PubMed  PubMed Central  Google Scholar 

  6. Farooq MU, Min J, Goshgarian C et al (2017) Pharmacotherapy for vascular cognitive impairment. CNS Drugs 31(9):759–776

    Article  CAS  PubMed  Google Scholar 

  7. Cui L, Li P, Zhang J et al (2022) Exploring the effect of enbrel softgels on PWI indicators in VCIND patients. J Healthc Eng. 2022:9681235

    Article  PubMed  PubMed Central  Google Scholar 

  8. Zhang MM, Meng HY, Li HY (2020) Effect of 3R nursing combined with cognitive training on cognitive function and quality of life in patients with vascular cognitive impairment. Chin Foreign Med Res 18(19):99–101

  9. Zhang Y, Xu HX (2019) Effect of psychological nursing combined with hyperbaric oxygen on vascular cognitive impairment. Acta Inner Mong Med Coll. 41(1):93–96

  10. Omejc N, Rojc B, Battaglini PP et al (2019) Review of the therapeutic neurofeedback method using electroencephalography: EEG Neurofeedback. Bosn J Basic Med Sci 19(3):213–220

    PubMed  PubMed Central  Google Scholar 

  11. Tolin DF, Davies CD, Moskow DM et al (2020) Biofeedback and neurofeedback for anxiety disorders: a quantitative and qualitative systematic review. Adv Exp Med Biol 1191:265–289

    Article  CAS  PubMed  Google Scholar 

  12. Ren XL, Zhu YQ, Sun YJ et al (2022) Effects of EEG biofeedback combined with repetitive transcranial magnetic stimulation on sleep disorders in elderly patients. Chin J Gerontol 42(13):3231–3234

  13. Qiu JM, Shen Y, Wu Q et al (2022) Intervention study of EEG biofeedback therapy on Internet addiction disorder in adolescent depression patients. Chin Med Innov 19(21):146–149

  14. Kong Y, Hu, JJ, Sun XR et al (2022) Effect of EEG biofeedback therapy on sleep quality in patients with schizophrenia. World J Sleep Med 9(07):1363–1365

  15. Nasreddine ZS, Phillips NA, Bédirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699 (published correction appears in J Am Geriatr Soc. 2019 Sep;67(9):1991)

    Article  PubMed  Google Scholar 

  16. Sachdev P, Kalaria R, O’Brien J et al (2014) Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord 28(3):206–218

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Jia X, Wang Z, Huang F et al (2021) A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study. BMC Psychiatry 21(1):485

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kueper JK, Speechley M, Montero-Odasso M (2018) The Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A narrative review. J Alzheimers Dis 63(2):423–444

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bagby RM, Ryder AG, Schuller DR et al (2004) The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 161(12):2163–2177

    Article  PubMed  Google Scholar 

  20. Wei ZY, Gu SL, Zhang T (2018) Analysis of the effect of electronic biofeedback therapy on vascular dementia. J Clin Exp Med 17(24):2649–2652

  21. Liu YQ (2020) Effect of oxiracetam combined with electromyography biofeedback therapy on vascular dementia. J Math Med 33(05):754–755

  22. Acevedo BP, Dattatri N, Le J, Lappinga C, Collins NL (2022) Cognitive training with neurofeedback using fNIRS improves cognitive function in older adults. Int J Environ Res Public Health 19(9):5531

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lavy Y, Dwolatzky T, Kaplan Z et al (2019) Neurofeedback improves memory and peak alpha frequency in individuals with mild cognitive impairment. Appl Psychophysiol Biofeedback 44(1):41–49

    Article  PubMed  Google Scholar 

  24. Qiu SJ (2017) Progress in clinical research on vascular dementia and vascular cognitive impairment. Med Theory Pract. 30(06):803–804

  25. Guan Q, Hu XH, Ma N et al (2020) Sleep quality, depression, and cognitive function in non-demented older adults. J Alzheimers Dis 76(4):1637–1650

  26. Czerwińska A, Pawłowski T (2020) Cognitive dysfunctions in depression - significance, description and treatment prospects. Psychiatr Pol 54(3):453–466

    Article  PubMed  Google Scholar 

  27. Melnikov MY (2021) The current evidence levels for biofeedback and neurofeedback interventions in treating depression: a narrative review. Neural Plast 2021:8878857

    Article  PubMed  PubMed Central  Google Scholar 

  28. Maynart W, Albuquerque M, Santos RCS et al (2021) The use of biofeedback intervention in the improvement of depression levels: a randomised trial. Acta Neuropsychiatr 33(3):126–133

    Article  PubMed  Google Scholar 

  29. Fernández-Alvarez J, Grassi M, Colombo D et al (2022) Efficacy of bio- and neurofeedback for depression: a meta-analysis. Psychol Med 52(2):201–216

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

This study was supported by the Hebei Medical Science Research Key Project (No.: 20180230). Funding agencies did not play a role in study design, data collection, analysis and interpretation, and manuscript writing.

Author information

Author notes

  1. Hongmin Wang and Xin Zhang have contributed equally to this study.

Authors and Affiliations

  1. Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China

    Hongmin Wang, Xin Zhang, Peizhi Wang, Guining Dai & Li Liu

  2. Department of Hepatology, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China

    Yanfang Xu

  3. Neurological Function Examination Center, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China

    Huijun Wang

  4. Department of Oncology, The First Hospital of Hebei Medical University, No. 89 of Donggang Road, Yuhua District, Shijiazhuang, 050031, Hebei, China

    Yongqian Zhang

Authors
  1. Hongmin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peizhi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guining Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Li Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yanfang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Huijun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yongqian Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YZ conceived of the study, and HW, XZ, PW, GD, LL, YX and HW participated in its design and data analysis and statistics and HW and XZ helped to draft the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yongqian Zhang.

Ethics declarations

Conflict of interest

All of the authors had no any personal, financial, commercial, or academic conflicts of interest separately.

Consent for publication

Not applicable.

Ethics approval and consent to participate

This study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of the First Hospital of Hebei Medical University(No.20170563).Written informed consent was obtained from all participants.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Zhang, X., Wang, P. et al. Study of electronic biofeedback combined with nursing intervention in the treatment of vascular cognitive impairment-no dementia. Acta Neurol Belg (2024). https://doi.org/10.1007/s13760-023-02471-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13760-023-02471-z

Keywords

Search

Navigation